Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geza Halasz

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Preventive Cardiology|September 5, 2023
Cost-effectiveness and diagnostic accuracy of focused cardiac ultrasound in the pre-participation screening of athletes: the SPORT-FoCUS studyGeza Halasz, Bruno Capelli, Alessia Nardecchia, et al.
Healthcare (Basel, Switzerland)|June 12, 2026
Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative ReviewGeza Halasz, Raffaella Mistrulli, Marco Di Francesco, et al.
European Journal of Clinical Pharmacology|May 22, 2023
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experienceEmilio Attena, Alfredo Caturano, Anna Annunziata, et al.
Frontiers in Cardiovascular Medicine|August 23, 2024
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical settingGaetano Todde, Lorenzo Lupo Dei, Roberto Polizzi, et al.
JACC. Advances|October 29, 2025
Identifying Cardiogenic Shock Sub-Phenotypes with Machine Learning: A Multicenter Study Combining Clinical and Echocardiographic DataNicolò Ghionzoli, Andrea Stefanini, Geza Halasz, et al.
Journal of Medical Internet Research|May 17, 2021
A Machine Learning Approach for Mortality Prediction in COVID-19 Pneumonia: Development and Evaluation of the Piacenza ScoreGeza Halasz, Michela Sperti, Matteo Villani, et al.
Journal of Clinical Medicine|December 30, 2025
Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEFMaria Denitza Tinti, Luisa De Gennaro, Raul Limonta, et al.
Giornale Italiano Di Cardiologia (2006)|December 23, 2024
[Mineralocorticoid receptor antagonists in heart failure with preserved/mildly reduced ejection fraction: from TOPCAT to FINEARTS-HF]Maria Denitza Tinti, Luisa De Gennaro, Emilia D'Elia, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Role of inflammation in heart failure with preserved ejection fraction: from nephro-metabolic interactions to future therapeutic implications]Emilia D'Elia, Manuela Benvenuto, Ilaria Battistoni, et al.
European Journal of Preventive Cardiology|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Preventive Cardiology|September 5, 2023
Cost-effectiveness and diagnostic accuracy of focused cardiac ultrasound in the pre-participation screening of athletes: the SPORT-FoCUS studyGeza Halasz, Bruno Capelli, Alessia Nardecchia, et al.
Healthcare (Basel, Switzerland)|June 12, 2026
Integrating Cardiopulmonary Exercise Testing, Stress Echocardiography and Near-Infrared Spectroscopy for Multimodal Assessment of Exercise Intolerance: A Narrative ReviewGeza Halasz, Raffaella Mistrulli, Marco Di Francesco, et al.
European Journal of Clinical Pharmacology|May 22, 2023
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experienceEmilio Attena, Alfredo Caturano, Anna Annunziata, et al.
Frontiers in Cardiovascular Medicine|August 23, 2024
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical settingGaetano Todde, Lorenzo Lupo Dei, Roberto Polizzi, et al.
JACC. Advances|October 29, 2025
Identifying Cardiogenic Shock Sub-Phenotypes with Machine Learning: A Multicenter Study Combining Clinical and Echocardiographic DataNicolò Ghionzoli, Andrea Stefanini, Geza Halasz, et al.
Journal of Medical Internet Research|May 17, 2021
A Machine Learning Approach for Mortality Prediction in COVID-19 Pneumonia: Development and Evaluation of the Piacenza ScoreGeza Halasz, Michela Sperti, Matteo Villani, et al.
Journal of Clinical Medicine|December 30, 2025
Finerenone: Extending MRAs Prognostic Benefit to the Recently Hospitalized and More Symptomatic Patient with HFpEFMaria Denitza Tinti, Luisa De Gennaro, Raul Limonta, et al.
Giornale Italiano Di Cardiologia (2006)|December 23, 2024
[Mineralocorticoid receptor antagonists in heart failure with preserved/mildly reduced ejection fraction: from TOPCAT to FINEARTS-HF]Maria Denitza Tinti, Luisa De Gennaro, Emilia D'Elia, et al.
Giornale Italiano Di Cardiologia (2006)|March 25, 2025
[Role of inflammation in heart failure with preserved ejection fraction: from nephro-metabolic interactions to future therapeutic implications]Emilia D'Elia, Manuela Benvenuto, Ilaria Battistoni, et al.
European Journal of Preventive Cardiology|March 12, 2025
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of CardiologyMaurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, et al.
Pageof 11